Protein misfolding cyclic amplification of infectious prions

Rodrigo Morales1, Claudia Duran-Aniotz, Rodrigo Diaz-Espinoza

  • 1Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, University of Texas Houston Medical School, Houston, Texas, USA.

Nature Protocols
|June 30, 2012
PubMed

Insights

Protein misfolding cyclic amplification (PMCA) allows laboratory cultivation of prions, enabling faster study of prion diseases. This technique mimics prion replication, aiding research in food safety and diagnostics.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Biochemistry

Background:

  • Prions are infectious agents causing fatal neurodegenerative diseases.
  • Studying prions is challenging due to the lack of laboratory cultivation methods.
  • Understanding prion conversion (PrP(C) to PrP(Sc)) is crucial.

Purpose of the Study:

  • To present Protein Misfolding Cyclic Amplification (PMCA) as a method for prion replication.
  • To highlight PMCA's efficiency and speed in mimicking prion propagation.
  • To demonstrate PMCA's utility in prion disease research.

Main Methods:

  • Incubating infectious prions with normal prion protein (PrP(C)).
  • Utilizing cycles of sonication to fragment and amplify converting units.
  • Mimicking prion replication in vitro.

Main Results:

  • PMCA replicates prions efficiently in vitro within days.
  • The method can detect minute amounts of infectious PrP(Sc).
  • Replicated prions retain infectivity, strain properties, and species specificity.

Conclusions:

  • PMCA is a powerful tool for studying prion biology and disease.
  • This technique accelerates prion replication compared to in vivo methods.
  • PMCA has broad applications in diagnostics and safety testing.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...